dc.contributor.author | Williams, CA | |
dc.contributor.author | Saynor, ZL | |
dc.contributor.author | Barker, AR | |
dc.contributor.author | Oades, PJ | |
dc.contributor.author | Tomlinson, OW | |
dc.date.accessioned | 2017-11-03T14:48:40Z | |
dc.date.issued | 2017-10-01 | |
dc.identifier.citation | Vol. 123 (4), article 1017 | en_GB |
dc.identifier.doi | 10.1152/japplphysiol.00538.2017 | |
dc.identifier.uri | http://hdl.handle.net/10871/30148 | |
dc.language.iso | en | en_GB |
dc.publisher | American Physiological Society | en_GB |
dc.relation.url | https://www.ncbi.nlm.nih.gov/pubmed/29074571 | en_GB |
dc.rights.embargoreason | Publisher policy | en_GB |
dc.rights | Copyright © 2017 the American Physiological Society | en_GB |
dc.title | Measurement of V̇o2max in clinical groups is feasible and necessary | en_GB |
dc.type | Article | en_GB |
exeter.place-of-publication | United States | en_GB |
dc.description | This is the author accepted manuscript. The final version is available from American Physiological Society via the DOI in this record. | en_GB |
dc.identifier.journal | Journal of Applied Physiology | en_GB |